[Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].

INTRODUCTION

The use of inhaled treatments for chronic obstructive pulmonary disease (COPD) in France follows the management proposals issued by the Société de Pneumologie de Langue Française (SPLF). We conducted a retrospective study in two hospitals in Alsace, France to determine the rate of compliance with the recommended treatments.

METHODS

Data were collected from patients with follow-up for COPD between August 2022 and January 2023. Asthma-COPD Overlap and Overlap syndrome phenotypes were excluded from the study. The data were extracted from the patient's most recent pulmonology consultation at one of the two centers.

RESULTS

Out of the 250 patients recruited, 183 (73.2%) had compliant prescriptions. Among those with non-compliant prescriptions, 38 exhibited over-prescribing (56.7%), often secondary to inappropriate use of inhaled corticosteroids (ICS), while 29 cases showed under-prescribing (43.3%), due mainly to lack of treatment with long-acting bronchodilators.

CONCLUSIONS

Treatment prescription in COPD remains sub-optimal, with a high proportion of therapeutic non-conformities, especially the over-prescribing of ICS. Further studies are needed to develop strategies for improving prescribing practices.